Evidence map›Paper›PMID 35585559›Full record

ArticleAlzheimer's research & therapy2022

Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort.

Leslie Grasset, Cécile Proust-Lima, Jean-François Mangin, Marie-Odile Habert, Bruno Dubois, Claire Paquet, Olivier Hanon, Audrey Gabelle, Mathieu Ceccaldi, Cédric Annweiler and 11 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Selected social and lifestyle correlates of brain health markers: the Cross-Cohort Collaboration Consortium.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. A lifespan perspective on cognitive reserve and risk for dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Global rural health disparities in Alzheimer's disease and related dementias: State of the science.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 2 countries.

Leslie GrassetUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inserm, CIC1401-EC, F-33000, Bordeaux, France. leslie.grasset@u-bordeaux.fr.
Cécile Proust-LimaUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inserm, CIC1401-EC, F-33000, Bordeaux, France.
Jean-François ManginCATI Multicenter Neuroimaging Platform, 75000, Paris, France.
Marie-Odile HabertCATI Multicenter Neuroimaging Platform, 75000, Paris, France.
Bruno DuboisIM2A AP-HP INSERM UMR-S975 Groupe Hospitalier Pitié-Salpêtrière Institut de La Mémoire Et de La Maladie d'Alzheimer, Institut du Cerveau Et de La Moelle Épinière Sorbonne, Université Paris, Paris, France.
Claire PaquetCentre de Neurologie Cognitive Hôpital Lariboisière, Université de Paris, INSERMU1144, F-75010, Paris, France.
Olivier HanonGeriatric Department Broca Hospital, Université Paris Descartes, Sorbonne Paris Cité, APHP, EA 4468, F-75013, Paris, France.
Audrey GabelleCentre Mémoire Ressources Recherche Département de Neurologie CHU Gui de Chauliac, 34000, Montpellier, France.
Mathieu CeccaldiCMMR PACA Ouest CHU Timone APHM & Aix Marseille Univ INSERM INS Inst Neurosci Syst, 13000, Marseille, France.
Cédric AnnweilerDepartment of Geriatric Medicine, Research Center On Autonomy and Longevity; UPRES EA 4638, Angers University HospitalAngers University Memory ClinicUniversity of Angers, 49000, Angers, France.
Renaud DavidCentre Mémoire de Ressources et de Recherche (CMRR) - CHU Nice, Centre de Recherche Edmond Et Lily SAFRA, CoBTeK "Cognition Behaviour Technology" - Université Côte d'Azur, Institut Claude Pompidou, EA 7276, 06000, Nice, France.
Therese JonveauxCentre Mémoire de Ressources Et de Recherche de Lorraine, Laboratoire Lorrain de Psychologie Et de Neurosciences de La Dynamique Des Comportements, Unité Cognitivo Comportementale CHRU Nancy, Université de Lorraine, 2LPN EA 7489, 54000, Nancy, France.
Catherine BelinService de Neurologie Hôpital Saint-Louis AP-HP, 75010, Paris, France.
Adrien JulianService de Neurologie CHU La Milétrie Centre Mémoire de Ressources Et de Recherche, 86000, Poitiers, France.
Isabelle Rouch-LeroyerCellule Régionale d'observation de La Maladie d'Alzheimer Et Des Maladies Apparentées, CHU de Saint Etienne, 42000, Saint-Etienne, France.
Jérémie ParienteDepartment of Neurology, Toulouse University Hospital, 31000, Toulouse, France.
Maxime LocatelliCATI Multicenter Neuroimaging Platform, 75000, Paris, France.
Marie ChupinCATI Multicenter Neuroimaging Platform, 75000, Paris, France.
Geneviève Chêne *University of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inserm, CIC1401-EC, F-33000, Bordeaux, France.
Carole Dufouil *University of Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inserm, CIC1401-EC, F-33000, Bordeaux, France.
Memento Cohort Study group
Inserm · FRUniversité de Bordeaux · FRCentre National de la Recherche Scientifique · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Poitiers · FRCentre Hospitalier Universitaire de Saint-Étienne · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRLaboratoire lorrain de psychologie et neurosciences de la dynamique des comportementsUniversité Côte d'Azur · FRUniversité Paris Cité · FRUniversité Toulouse III - Paul Sabatier · FRWestern University · CA

Funding

Medical Research Council MR/L023784/2
6 · The paper itself

Abstract

backgroundThis work aimed to investigate the potential pathways involved in the association between social and lifestyle factors, biomarkers of Alzheimer's disease and related dementia (ADRD), and cognition.

methodsThe authors studied 2323 participants from the Memento study, a French nationwide clinical cohort. Social and lifestyle factors were education level, current household incomes, physical activity, leisure activities, and social network from which two continuous latent variables were computed: an early to midlife (EML) and a latelife (LL) indicator. Brain magnetic resonance imaging (MRI), lumbar puncture, and amyloid-positron emission tomography (PET) were used to define three latent variables: neurodegeneration, small vessel disease (SVD), and AD pathology. Cognitive function was defined as the underlying factor of a latent variable with four cognitive tests. Structural equation models were used to evaluate cross-sectional pathways between social and lifestyle factors and cognition.

resultsParticipants' mean age was 70.9 years old, 62% were women, 28% were apolipoprotein-ε4 carriers, and 59% had a Clinical Dementia Rating (CDR) score of 0.5. Higher early to midlife social indicator was only directly associated with better cognitive function (direct β = 0.364 (0.322; 0.405), with no indirect pathway through ADRD biomarkers (total β = 0.392 (0.351; 0.429)). In addition to a direct effect on cognition (direct β = 0.076 (0.033; 0.118)), the association between latelife lifestyle indicator and cognition was also mostly mediated by an indirect effect through lower neurodegeneration (indirect β = 0.066 (0.042; 0.090) and direct β =  - 0.116 (- 0.153; - 0.079)), but not through AD pathology nor SVD.

conclusionsEarly to midlife social factors are directly associated with higher cognitive functions. Latelife lifestyle factors may help preserve cognitive functions through lower neurodegeneration.

Indexed as

Alzheimer DiseaseCognitive DysfunctionVascular DiseasesAgedAmyloid beta-PeptidesBiomarkersCognitionCross-Sectional StudiesFemaleHumansLife StyleMagnetic Resonance ImagingMalePositron-Emission TomographyAmyloid beta-PeptidesBiomarkersBrain markersCognitive functionLifestyle factorsPathologyPathwaysSocial factors

Identifiers

PMID35585559
PMCPMC9115948
OpenAlexW4280602597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.